» Articles » PMID: 32102369

The Translocator Protein (TSPO) in Mitochondrial Bioenergetics and Immune Processes

Overview
Journal Cells
Publisher MDPI
Date 2020 Feb 28
PMID 32102369
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The translocator protein (TSPO) is an outer mitochondrial membrane protein that is widely used as a biomarker of neuroinflammation, being markedly upregulated in activated microglia in a range of brain pathologies. Despite its extensive use as a target in molecular imaging studies, the exact cellular functions of this protein remain in question. The long-held view that TSPO plays a fundamental role in the translocation of cholesterol through the mitochondrial membranes, and thus, steroidogenesis, has been disputed by several groups with the advent of TSPO knockout mouse models. Instead, much evidence is emerging that TSPO plays a fundamental role in cellular bioenergetics and associated mitochondrial functions, also part of a greater role in the innate immune processes of microglia. In this review, we examine the more direct experimental literature surrounding the immunomodulatory effects of TSPO. We also review studies which highlight a more central role for TSPO in mitochondrial processes, from energy metabolism, to the propagation of inflammatory responses through reactive oxygen species (ROS) modulation. In this way, we highlight a paradigm shift in approaches to TSPO functioning.

Citing Articles

Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data.

Nelli F, Ruggeri E, Virtuoso A, Giannarelli D, Raso A, Natoni F Explor Target Antitumor Ther. 2025; 6:1002287.

PMID: 40061137 PMC: 11886376. DOI: 10.37349/etat.2025.1002287.


Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease.

Meng T, Zhang Y, Ye Y, Li H, He Y Eur J Med Res. 2025; 30(1):89.

PMID: 39920860 PMC: 11806906. DOI: 10.1186/s40001-025-02297-w.


Molecular imaging of viral pathogenesis and opportunities for the future.

Kelly B, Boudreau J, Beyea S, Brewer K Npj Imaging. 2025; 3(1):3.

PMID: 39872292 PMC: 11761071. DOI: 10.1038/s44303-024-00056-w.


Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway.

Li B, Yu K, Zhou X, Sun J, Qi L, Li W J Headache Pain. 2025; 26(1):16.

PMID: 39871133 PMC: 11771075. DOI: 10.1186/s10194-025-01953-0.


Evidence for glial reactivity using positron-emission tomography imaging of translocator Protein-18 kD [TSPO] in both sham and nerve-injured rats in a preclinical model of orofacial neuropathic pain.

Emvalomenos G, Kang J, Salberg S, Li C, Jupp B, Long M Neurobiol Pain. 2025; 17:100175.

PMID: 39758133 PMC: 11699482. DOI: 10.1016/j.ynpai.2024.100175.


References
1.
Mills C, Makwana M, Wallace A, Benn S, Schmidt H, Tegeder I . Ro5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats. Eur J Neurosci. 2008; 27(4):937-46. DOI: 10.1111/j.1460-9568.2008.06065.x. View

2.
Wang H, Zhai K, Xue Y, Yang J, Yang Q, Fu Y . Global Deletion of TSPO Does Not Affect the Viability and Gene Expression Profile. PLoS One. 2016; 11(12):e0167307. PMC: 5131929. DOI: 10.1371/journal.pone.0167307. View

3.
Azrad M, Zeineh N, Weizman A, Veenman L, Gavish M . The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS. Int J Mol Sci. 2019; 20(3). PMC: 6387401. DOI: 10.3390/ijms20030594. View

4.
Orihuela R, McPherson C, Harry G . Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2015; 173(4):649-65. PMC: 4742299. DOI: 10.1111/bph.13139. View

5.
Kupa L, Drewes C, Barioni E, Neves C, Sampaio S, Farsky S . Role of Translocator 18 KDa Ligands in the Activation of Leukotriene B4 Activated G-Protein Coupled Receptor and Toll Like Receptor-4 Pathways in Neutrophils. Front Pharmacol. 2017; 8:766. PMC: 5664262. DOI: 10.3389/fphar.2017.00766. View